Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Mirati Therapeutics, Inc. (MRTX)

« Back to company index

MRTX Chatter Timeline

Stock Ticker for MRTX

Most Active Tweeters for MRTX

UserTweets
@thefinreviewer 9
@reurope_stock 7
@bulletin_en 7
@EnterpriseLeade 7
@registrarjourn 7

Recent Tweets for MRTX

stockmktgenius @stockmktgenius
$MRTX Mirati Therapeutics, Inc. Top stock up 194% from low. Close: 75.35 VolvsAvg: 0.66 Liq: $35M https://t.co/9N6zhpHCmr
March 21st 2019, 9:03pm
whatsonthorold2 @whatsonthorold2
Mirati Therapeutics, Inc. $MRTX has analysts on the Bullish side this week. https://t.co/gyliGnufdW
March 21st 2019, 2:03pm
dispatchtribune @dispatchtribune
Venbio Select Advisor Llc Sells 23,781 Shares of Mirati Therapeutics Inc $MRTX Stock https://t.co/L0npolkYcX
March 21st 2019, 1:03pm
EnterpriseLeade @EnterpriseLeade
Mirati Therapeutics Inc $MRTX Major Shareholder Venbio Select Advisor Llc Sells 23,781 Shares of Stock https://t.co/X1NlkinS2k
March 21st 2019, 1:03pm
registrarjourn @registrarjourn
Mirati Therapeutics Inc $MRTX Major Shareholder Venbio Select Advisor Llc Sells 23,781 Shares of Stock https://t.co/NX4c8OdhR7
March 21st 2019, 1:03pm
macondailynews @macondailynews
Mirati Therapeutics Inc $MRTX Major Shareholder Venbio Select Advisor Llc Sells 125,000 Shares of Stock https://t.co/oJaj5bjmCK
March 21st 2019, 1:03pm
TheMarketsDaily @TheMarketsDaily
Venbio Select Advisor Llc Sells 125,000 Shares of Mirati Therapeutics Inc $MRTX Stock https://t.co/OmTEZa4PtJ
March 21st 2019, 12:03pm
BlogYomi @BlogYomi
Mirati Therapeutics, Inc. $MRTX's Stock Insider Trade - Venbio Select Advisor Llc Unloaded 248,781 Shares; Carrizo… https://t.co/POnp3e26da
March 21st 2019, 6:03am
registrarjourn @registrarjourn
Oppenheimer Reiterates Buy Rating for Mirati Therapeutics $MRTX https://t.co/gr6XLgskvx
March 21st 2019, 4:03am
EnterpriseLeade @EnterpriseLeade
Oppenheimer Reiterates Buy Rating for Mirati Therapeutics $MRTX https://t.co/0nsHOT8Gwh
March 21st 2019, 4:03am
dispatchtribune @dispatchtribune
Oppenheimer Reiterates Buy Rating for Mirati Therapeutics $MRTX https://t.co/ZtvzKSQili
March 21st 2019, 4:03am
ConsumerFeed @ConsumerFeed
Mirati Therapeutics Inc $MRTX Major Shareholder Sells $9,568,750.00 in Stock https://t.co/lIIqCP93fS
March 20th 2019, 5:03pm
TickerReport @TickerReport
Insider Selling: Mirati Therapeutics Inc $MRTX Major Shareholder Sells 23,781 Shares of Stock https://t.co/T5RBLm3fRY
March 20th 2019, 5:03pm
InsiderAlertsIA @InsiderAlertsIA
$MRTX: New Insider Filing on 10%+ Owner VENBIO SELECT ADVISOR LLC: https://t.co/8qBG5EgWon
March 20th 2019, 4:03pm
RTFilingsStocks @RTFilingsStocks
venBio Select Advisor LLC files Form 4 for $MRTX Sold 248781 shares Price range: $72.8-76.55 Transaction Dates: 3/1… https://t.co/iEjb2YOObU
March 20th 2019, 4:03pm
bibeypost_stock @bibeypost_stock
As Mirati Therapeutics INC $MRTX Share Price Rose, Broadfin Capital LLC Has Decreased Its Holding https://t.co/rosAoSkfar
March 20th 2019, 3:03pm
dakotafinancial @dakotafinancial
Mirati Therapeutics $MRTX Hits New 12-Month High at $80.00 https://t.co/13ozyVsFbx
March 20th 2019, 11:03am
ThisLincolnian @ThisLincolnian
Mirati Therapeutics’ $MRTX “Buy” Rating Reaffirmed at Oppenheimer https://t.co/fUBaFivNAa
March 20th 2019, 10:03am
thefinreviewer @thefinreviewer
IntelliPharmaCeutics International Inc. $MRTX Comparing side by side https://t.co/5VdP9NcSam
March 19th 2019, 11:03pm
ShortSqueezed1 @ShortSqueezed1
@George323818 Its not out of the question, if the company can maintain the course $MRTX has been a stock in play fo… https://t.co/8NNLbmO064
March 19th 2019, 10:03pm
mmahotstuff1 @mmahotstuff1
Oppenheimer Reiterates The Buy Rating They’ve had for Mirati Therapeutics $MRTX Shares https://t.co/RmlBraDb7W
March 19th 2019, 8:03pm
whatsonthorold2 @whatsonthorold2
Analyst at Oppenheimer Kept The Mirati Therapeutics $MRTX Buy Rating They’ve Had https://t.co/3Ii48POiLW
March 19th 2019, 8:03pm
bibeypost_stock @bibeypost_stock
Analyst at Oppenheimer Reiterates The Mirati Therapeutics $MRTX Buy Rating They’ve Had https://t.co/qrfvxxGJkn
March 19th 2019, 8:03pm
reurope_stock @reurope_stock
Mirati Therapeutics $MRTX Rating Reaffirmed by Oppenheimer Today https://t.co/dyp7CwtSEq
March 19th 2019, 8:03pm
bibeypost_stock @bibeypost_stock
What's Next for Mirati Therapeutics, Inc. $MRTX After Today's Significant Decline? https://t.co/ciuaerAbuS
March 19th 2019, 3:03pm
AmericanBanking @AmericanBanking
Mirati Therapeutics $MRTX Earns Buy Rating from Oppenheimer https://t.co/hKGiw2bC86 #stocks
March 19th 2019, 3:03pm
macondailynews @macondailynews
Mirati Therapeutics’ $MRTX Buy Rating Reiterated at Oppenheimer https://t.co/bOgKDn6jsh
March 19th 2019, 2:03pm
dakotafinancial @dakotafinancial
Oppenheimer Reaffirms Buy Rating for Mirati Therapeutics $MRTX https://t.co/wOGkDVzoxr
March 19th 2019, 2:03pm
bulletin_en @bulletin_en
Mirati Therapeutics, Inc. $MRTX Decreased to $73.81 https://t.co/xsHRGrROEo
March 19th 2019, 2:03pm
QuantchaIdeas @QuantchaIdeas
Covered Call Alert: MIRATI THERAPEUTICS INC. COMM $MRTX returning up to 20.68% through 21-Jun-2019… https://t.co/SVSmgPdNyi
March 19th 2019, 12:03pm
UlmHi @UlmHi
Td Asset Management Has Cut Its Foot Locker $FL Stake; Mirati Therapeutics, Inc. $MRTX Had 4 Analysts Last Week https://t.co/Xmd9xi0lpu
March 19th 2019, 12:03pm
dakotafinancial @dakotafinancial
Brokerages Expect Mirati Therapeutics Inc $MRTX Will Announce Earnings of -$0.94 Per Share https://t.co/Ku2hSXrXao
March 19th 2019, 10:03am
AmericanBanking @AmericanBanking
Brokerages Expect Mirati Therapeutics Inc $MRTX Will Announce Earnings of -$0.94 Per Share https://t.co/Vq5PIjFDas #stocks
March 19th 2019, 10:03am
macondailynews @macondailynews
Zacks: Analysts Expect Mirati Therapeutics Inc $MRTX Will Announce Earnings of -$0.94 Per Share https://t.co/AMiyxBrsSA
March 19th 2019, 10:03am
UlmHi @UlmHi
Reviewing Ascendis Pharma A/S $MRTX's results https://t.co/zTShYJbHHD
March 19th 2019, 12:03am
stockmktgenius @stockmktgenius
$MRTX Mirati Therapeutics, Inc. Top stock up 194% from low. Close: 76.29 VolvsAvg: 0.71 Liq: $45M https://t.co/9N6zhpHCmr
March 18th 2019, 9:03pm
ZolmaxNews @ZolmaxNews
Mirati Therapeutics $MRTX Hits New 52-Week High at $80.00 https://t.co/QlRQg2rLjm
March 18th 2019, 8:03pm
bulletin_en @bulletin_en
Mirati Therapeutics, Inc. $MRTX Is At Record High at $75.69 on Mar, 18 https://t.co/9Vdb2nwyl5
March 18th 2019, 1:03pm
bulletin_en @bulletin_en
Mirati Therapeutics Inc $MRTX Big Money Sentiment Is 1.11 https://t.co/CzW8qIdHWq
March 18th 2019, 1:03pm
reurope_stock @reurope_stock
Mirati Therapeutics, Inc. $MRTX Can't Burn Your Long Portfolio. Just Reaches Record High https://t.co/MnAJMwkxzn
March 18th 2019, 12:03pm
Jon12508683 @Jon12508683
$mrtx another ath. ??
March 18th 2019, 10:03am
BlogYomi @BlogYomi
Brookside Capital Management Decreased Its Mirati Therapeutics $MRTX Position by $9.96 Million; Market Value Rose;… https://t.co/Svpilj2TBI
March 18th 2019, 7:03am
whatsonthorold2 @whatsonthorold2
Mirati Therapeutics Inc $MRTX Stock Sentiment Worsens https://t.co/UfNbIC2m2x
March 18th 2019, 7:03am
BlogYomi @BlogYomi
Yorktown Management & Research Co Cut Its At&T $T Stake; Mirati Therapeutics $MRTX SI Increased By 2.6% https://t.co/9CJViEIwr0
March 17th 2019, 1:03pm
FinZTribune @FinZTribune
Broadfin Capital LLC Decreased Its Stake in Mirati Therapeutics INC $MRTX by $6.62 Million https://t.co/8stV4RXJOI
March 17th 2019, 12:03pm
bulletin_en @bulletin_en
Mirati Therapeutics INC $MRTX Shareholder Broadfin Capital LLC Decreased Its Stake by $6.62 Million as Shares Rose https://t.co/5BP0ZmqOQl
March 17th 2019, 12:03pm
ArizetSignals @ArizetSignals
17 MAR 2019 - Week's Top Gainers $MRTX @ $76.31 1-Week Return: 12.55% Combined Score: +72.0 Sentiment: BULLISH Conf… https://t.co/Bo73SyK75U
March 17th 2019, 11:03am
whatsonthorold2 @whatsonthorold2
Can Mirati Therapeutics Inc $MRTX’s Tomorrow be Different? The Stock Had Increase in Shorts https://t.co/MQSuhC8Qn2
March 17th 2019, 10:03am
dakotafinancial @dakotafinancial
Mirati Therapeutics’ $MRTX “Buy” Rating Reiterated at Cowen https://t.co/SUGgE0l6Uo
March 17th 2019, 9:03am
thefinreviewer @thefinreviewer
Sol-Gel Technologies Ltd. $MRTX Contrasting side by side https://t.co/zojrsMA1Ql
March 17th 2019, 2:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.